WEP CLINICAL AND WELLSTAT THERAPEUTICS CORPORATION ENTER INTO NEW PARTNERSHIP FOR THE NAMED PATIENT SUPPLY OF VISTOGARD® (URIDINE TRIACETATE)
WEP Clinical, the specialist pharmaceutical services company, announces that it has signed an exclusive supply agreement with Wellstat Therapeutics Corporation, the US biopharmaceutical company, to supply Vistogard in the EU and Australia on a [...]